Chad Hatfield, Pharm.D., MHA, BCPS, of UC Davis Health, discusses the system's pharmacy shared service center, embedded pharmacists and 340B rebate readiness.
Publication|Articles|July 25, 2024
Supplements And Featured Publications
- Update on RNA-Based Technology
Update on RNA-based technology
Advertisement
This supplement provides an overview of RNA-based technology, reviews current RNA-based applications, and explores the potential of RNA-based therapeutics.
This publication was paid for and developed under the direction of Alnylam Pharmaceuticals, Inc.
Advertisement
Related to this article
Blood tests reveal early, widespread inflammation in hidradenitis suppurativa, linking biomarkers to disease severity, quality of life, smoking, and potential cardiovascular risk.
UCLA research suggests that GLP-1 therapies may protect bone health in Type 2 diabetes patients.
A study with three years of follow-up shows that the drug stays effective and safe for most, although 16% stopped getting treated with Dupixent, mainly because it was ineffective or caused side effects.
Heart disease became the leading cause of death among Hispanic adults in the U.S. in 2022, and a new American Heart Association statement says risk varies by heritage, with gaps in coverage, language and food access adding to the burden.
A five-session course of transcranial magnetic stimulation (TMS) improved processing speed in people with schizophrenia, a cognitive domain that is among the most severely affected in patients,
National Alliance names Jenny Goins interim CEO after former leader’s arrest; details emerge on charges, firing timeline, and impact on healthcare policy circles.
Only 19% use AI predictive models in cancer care despite strong belief in impact; 2026 Oncology Care Index highlights reimbursement, training, funding barriers.
Advertisement
Advertisement